Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency

Platinum-based regimens have not been proved to increase survival from advanced prostate cancer (PCa). Incontrovertible evidence that a proportion of prostate cancers have homologous recombination DNA (HRD) repair defects, and that such genomic aberrations are synthetically lethal with both poly(ADP...

Descripción completa

Detalles Bibliográficos
Autores principales: Zafeiriou, Zafeiris, Bianchini, Diletta, Chandler, Robert, Rescigno, Pasquale, Yuan, Wei, Carreira, Suzanne, Barrero, Maialen, Petremolo, Antonella, Miranda, Susana, Riisnaes, Ruth, Rodrigues, Daniel Nava, Gurel, Bora, Sumanasuriya, Semini, Paschalis, Alec, Sharp, Adam, Mateo, Joaquin, Tunariu, Nina, Chinnaiyan, Arul M., Pritchard, Colin C., Kelly, Kevin, de Bono, Johann S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291437/
https://www.ncbi.nlm.nih.gov/pubmed/30340782
http://dx.doi.org/10.1016/j.eururo.2018.09.048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291437/
https://www.ncbi.nlm.nih.gov/pubmed/30340782
http://dx.doi.org/10.1016/j.eururo.2018.09.048

Ejemplares similares